CRL-2876 VCaP 人前列腺癌细胞 ATCC 细胞|细胞系|细胞株|肿瘤细胞|细胞；细胞库管理规范，提供的细胞株背景清楚，提供参考文献和优培养条件！...

 CRL-2876 VCaP 人前列腺癌细胞

Designations:	VCaP
Depositors:	KJ Pienta
Biosafety Level:	2 [(cells produce the mouse xenotropic retrovirus Bxv-1) ]
Shipped:	frozen
Medium & Serum:	See Propagation
Growth Properties:	adherent
Organism:	Homo sapiens
Source:	Organ: prostate  Tissue: vertebral metastasis  Disease: cancer  Cell Type: epithelial
Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Isolation:	Isolation date: 1997
Applications:	This line was established in 1997 from a vertebral bone metastasis from a patient with hormone refractory prostate cancer.
Tumorigenic:	Yes
Antigen expression:	cytokeratin-18; Homo sapiens, expressed  p53 antigen; Homo sapiens, expressed  prostate specific antigen (PSA); Homo sapiens, expressed  prostatic acid phosphatase (PAP); Homo sapiens, expressed  Rb protein; Homo sapiens, expressed
DNA Profile (STR):	Amelogenin: X,Y  CSF1PO: 10,12  D13S317: 11,12  D16S539: 9  D5S818: 12  D7S820: 9,12  THO1: 9.3  TPOX: 8,11  vWA: 18,19
Age:	59 years
Gender:	male
Ethnicity:	Caucasian
Comments:	This line was established in 1997 from a vertebral bone metastasis from a patient with hormone refractory prostate cancer. It was passaged as xenografts in mice then cultured in vitro. It is androgen sensitive in vitro and in vivo.  Recently, it has been shown that VCaP prostate cancer cells produce the mouse xenotropic retrovirus Bxv-1, which was likely acquired by the cells during their xenotransplantation in mice.
Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. Atmosphere: air, 95%; carbon dioxide (CO2), 5%  Temperature: 37.0°C
Subculturing:	Protocol: Remove and discard culture medium. Briefly rinse the cell layer with Hank's Balanced Salt Solution or 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor. Add 1.0 to 2.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting. Add appropriate aliquots of the cell suspension to new culture vessels. An inoculum of 2 X 10(4) to 4 X 10(4) viable cells/sq. cm is recommended. Incubate cultures at 37°C. Interval: Subculture when the cell concentration reaches between 1 X 10(5) and 2 X 10(5) cells/sq. cm.  Subcultivation Ratio: 1:3 to 1:4
Preservation:	Freeze medium: 95% growth medium; 5% DMSO  Storage temperature: liquid nitrogen vapor phase
Doubling Time:	about 53 hours
Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002 recommended serum:ATCC 30-2020 0.25% (w/v) Trypsin - 0.53 mM EDTA in Hank' BSS (w/o Ca++, Mg++):ATCC 30-2101 Cell culture tested DMSO:ATCC 4-X Erythrosin B vital stain solution:ATCC 30-2404 Trypan Blue vital stain solution:ATCC 30-2402
References:	92253: Korenchuk S, et al. VCaP, a cell-based model system of human prostate cancer. In Vivo 15: 163-168, 2001. PubMed: 11317522 16173979: Knouf EC, et al. Multiple Integrated Copies and High-Level Production of the Human Retrovirus XMRV from 22Rv1 Prostate Carcinoma Cells. J. Virol. 83: 7353-7356, 2009. PubMed: 19403664 16173980: Sfanos KS, et al. Identification of replication competent murine gamma retroviruses in commonly used prostate cancer cell lines. PLoS One 6:e20874, 2011.

如果您觉得“CRL-2876 VCaP 人前列腺癌细胞.”描述资料不够齐全，请联系我们获取详细资料。(联系时请告诉我从仪器交易网看到的，我们将给您最大优惠！)
本页链接：http://www.yi7.com/com_xiangbio/sell/itemid-5890022.html
已经有1058位访客查看了本页.